SEC Form 4 · accession 0001185185-18-001879
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark P Borman
Director
Period of report
Oct 19, 2018
Accepted (ET)
Oct 26, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2018 | J | 526,918 | $0.027 | A | 526,942 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired in lieu of payment of costs incurred as a member of the Board of Directors (from 2009 to present) totaling $14,471.66.